ArticleBreast cancer research and treatment2022

Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer.

Luc Dirix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.